• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Metabolism of angiotensin peptides by angiotensin converting enzyme 2 (ACE2) and analysis of the effect of excess zinc on ACE2 enzymatic activity.血管紧张素肽的代谢由血管紧张素转换酶 2(ACE2)完成,并分析锌过量对 ACE2 酶活性的影响。
Peptides. 2021 Mar;137:170477. doi: 10.1016/j.peptides.2020.170477. Epub 2021 Jan 2.
2
Distinct roles for angiotensin-converting enzyme 2 and carboxypeptidase A in the processing of angiotensins within the murine heart.血管紧张素转换酶2和羧肽酶A在小鼠心脏内血管紧张素加工过程中的不同作用。
Exp Physiol. 2008 May;93(5):613-21. doi: 10.1113/expphysiol.2007.040246. Epub 2008 Mar 20.
3
Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism.血管紧张素转换酶(ACE)、其同源物ACE2及中性肽链内切酶在血管紧张素肽代谢中的评估
Biochem J. 2004 Oct 1;383(Pt 1):45-51. doi: 10.1042/BJ20040634.
4
Portal pressure responses and angiotensin peptide production in rat liver are determined by relative activity of ACE and ACE2.大鼠肝脏中的门静脉压力反应和血管紧张素肽生成由ACE和ACE2的相对活性决定。
Am J Physiol Gastrointest Liver Physiol. 2009 Jul;297(1):G98-G106. doi: 10.1152/ajpgi.00045.2009. Epub 2009 Apr 23.
5
Murine recombinant angiotensin-converting enzyme 2: effect on angiotensin II-dependent hypertension and distinctive angiotensin-converting enzyme 2 inhibitor characteristics on rodent and human angiotensin-converting enzyme 2.鼠源重组血管紧张素转化酶 2:对血管紧张素 II 依赖性高血压的影响以及对啮齿动物和人血管紧张素转化酶 2 的独特血管紧张素转化酶 2 抑制剂特性。
Hypertension. 2012 Sep;60(3):730-40. doi: 10.1161/HYPERTENSIONAHA.112.198622. Epub 2012 Jul 9.
6
Antagonism of angiotensin 1-7 prevents the therapeutic effects of recombinant human ACE2.血管紧张素1-7的拮抗作用会阻止重组人血管紧张素转换酶2的治疗效果。
J Mol Med (Berl). 2015 Sep;93(9):1003-13. doi: 10.1007/s00109-015-1285-z. Epub 2015 Apr 15.
7
Recombinant human angiotensin-converting enzyme 2 as a new renin-angiotensin system peptidase for heart failure therapy.重组人血管紧张素转换酶2作为心力衰竭治疗中一种新型肾素-血管紧张素系统肽酶。
Curr Heart Fail Rep. 2011 Sep;8(3):176-83. doi: 10.1007/s11897-011-0063-7.
8
ACE2, angiotensin-(1–7), and Mas: the other side of the coin.ACE2、血管紧张素-(1–7) 和 Mas:硬币的另一面。
Pflugers Arch. 2013 Jan;465(1):79-85. doi: 10.1007/s00424-012-1120-0.
9
Angiotensin metabolism in renal proximal tubules, urine, and serum of sheep: evidence for ACE2-dependent processing of angiotensin II.绵羊肾近端小管、尿液和血清中的血管紧张素代谢:血管紧张素 II 依赖 ACE2 加工的证据
Am J Physiol Renal Physiol. 2007 Jan;292(1):F82-91. doi: 10.1152/ajprenal.00139.2006. Epub 2006 Aug 8.
10
Renin-angiotensin system revisited.再探肾素-血管紧张素系统。
J Intern Med. 2008 Sep;264(3):224-36. doi: 10.1111/j.1365-2796.2008.01981.x.

引用本文的文献

1
Impact of zinc on immunometabolism and its putative role on respiratory diseases.锌对免疫代谢的影响及其在呼吸道疾病中的假定作用。
Immunometabolism (Cobham). 2025 Mar 5;7(1):e00057. doi: 10.1097/IN9.0000000000000057. eCollection 2025 Jan.
2
Pathobiological alterations affecting the distinct clinical courses of pediatric versus adult COVID-19 syndrome.影响儿童与成人 COVID-19 综合征不同临床病程的病理生物学改变。
Turk J Med Sci. 2023 May 31;53(5):1194-1204. doi: 10.55730/1300-0144.5685. eCollection 2023.
3
The Effect of Allicin on the Proteome of SARS-CoV-2 Infected Calu-3 Cells.大蒜素对感染SARS-CoV-2的Calu-3细胞蛋白质组的影响。
Front Microbiol. 2021 Oct 28;12:746795. doi: 10.3389/fmicb.2021.746795. eCollection 2021.
4
Zinc as a Drug for Wilson's Disease, Non-Alcoholic Liver Disease and COVID-19-Related Liver Injury.锌作为治疗 Wilson 病、非酒精性肝病和 COVID-19 相关肝损伤的药物。
Molecules. 2021 Oct 31;26(21):6614. doi: 10.3390/molecules26216614.

本文引用的文献

1
Broad host range of SARS-CoV-2 predicted by comparative and structural analysis of ACE2 in vertebrates.通过比较和结构分析脊椎动物 ACE2 预测 SARS-CoV-2 的广泛宿主范围。
Proc Natl Acad Sci U S A. 2020 Sep 8;117(36):22311-22322. doi: 10.1073/pnas.2010146117. Epub 2020 Aug 21.
2
What is the role of supplementation with ascorbic acid, zinc, vitamin D, or -acetylcysteine for prevention or treatment of COVID-19?补充抗坏血酸、锌、维生素D或N-乙酰半胱氨酸对预防或治疗新型冠状病毒肺炎有什么作用?
Cleve Clin J Med. 2020 Jun 8. doi: 10.3949/ccjm.87a.ccc046.
3
Can Zn Be a Critical Element in COVID-19 Treatment?锌能成为新冠肺炎治疗的关键元素吗?
Biol Trace Elem Res. 2021 Feb;199(2):550-558. doi: 10.1007/s12011-020-02194-9. Epub 2020 May 26.
4
Risks of ACE Inhibitor and ARB Usage in COVID-19: Evaluating the Evidence.在 COVID-19 中使用 ACE 抑制剂和 ARB 的风险:评估证据。
Clin Pharmacol Ther. 2020 Aug;108(2):236-241. doi: 10.1002/cpt.1863. Epub 2020 May 10.
5
Angiotensin receptor blockers and COVID-19.血管紧张素受体阻滞剂与 COVID-19。
Pharmacol Res. 2020 Jun;156:104832. doi: 10.1016/j.phrs.2020.104832. Epub 2020 Apr 15.
6
Response to recent commentaries regarding the involvement of angiotensin-converting enzyme 2 (ACE2) and renin-angiotensin system blockers in SARS-CoV-2 infections.对近期有关血管紧张素转换酶2(ACE2)和肾素-血管紧张素系统阻滞剂与严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染相关性的评论的回应
Drug Dev Res. 2020 Sep;81(6):643-646. doi: 10.1002/ddr.21672. Epub 2020 Apr 17.
7
Keep taking your ACE inhibitors and ARBs during the COVID 19 pandemic.在新冠疫情期间继续服用你的血管紧张素转换酶抑制剂和血管紧张素Ⅱ受体拮抗剂。
J Travel Med. 2020 May 18;27(3). doi: 10.1093/jtm/taaa045.
8
COVID-19, ACE2, and the cardiovascular consequences.新型冠状病毒肺炎、血管紧张素转化酶 2 与心血管系统并发症
Am J Physiol Heart Circ Physiol. 2020 May 1;318(5):H1084-H1090. doi: 10.1152/ajpheart.00217.2020. Epub 2020 Mar 31.
9
Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19.新冠病毒病患者中的肾素-血管紧张素-醛固酮系统抑制剂
N Engl J Med. 2020 Apr 23;382(17):1653-1659. doi: 10.1056/NEJMsr2005760. Epub 2020 Mar 30.
10
Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19.假说:血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂可能会增加 COVID-19 重症风险。
J Travel Med. 2020 May 18;27(3). doi: 10.1093/jtm/taaa041.

血管紧张素肽的代谢由血管紧张素转换酶 2(ACE2)完成,并分析锌过量对 ACE2 酶活性的影响。

Metabolism of angiotensin peptides by angiotensin converting enzyme 2 (ACE2) and analysis of the effect of excess zinc on ACE2 enzymatic activity.

机构信息

College of Pharmacy, University of Utrecht, Universiteitsweg 99, 3584 CG, Utrecht, the Netherlands; College of Pharmacy, Nova Southeastern University, Fort Lauderdale, FL, 33328, United States.

出版信息

Peptides. 2021 Mar;137:170477. doi: 10.1016/j.peptides.2020.170477. Epub 2021 Jan 2.

DOI:10.1016/j.peptides.2020.170477
PMID:33400951
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7887068/
Abstract

After decades of notoriety for its adverse cardiovascular, proinflammatory and profibrotic actions, the renin-angiotensin system (RAS) began to be cast in a more favorable light with the discovery of angiotensin-converting enzyme-2 (ACE2) in 2000. This monocarboxypeptidase, best known for its ability to metabolize angiotensin (Ang) II to Ang 1-7, counteracts the adverse effects of Ang II mediated by the AT Ang II receptor. Ang peptides are classically considered to be metabolized by aminopeptidases, by which the nomenclature Ang III (des-AspAng II, 2-8 heptapeptide) and Ang IV (des-Aspdes-ArgAng II, 3-8 hexapeptide) are derived. This report compares the ability of recombinant human ACE2 (rhACE2) to metabolize Ang III, Ang IV and Ang V, (4-8 pentapeptide) relative to Ang II to form corresponding des-omega-Phe metabolites. rhACE2 has highest affinity (lowest K) for Ang III, followed by Ang II ∼ Ang V, followed by Ang IV. However, rhACE2 has the highest Kcat for metabolising Ang IV followed by Ang V, Ang III and Ang II. The enzymatic efficiency (Kcat/Km) is highest for Ang V and Ang III followed by Ang IV and is lowest for Ang II. As a gluzincin metallopeptidase, ACE2 requires a zinc molecule at its active site for catalysis. This report also documents inhibition of ACE2 activity by concentrations of zinc exceeding 10 μM. These observations extend the functional significance of ACE2 to include the metabolic inactivation of Ang III, Ang IV and Ang V, reemphasizing the importance of monitoring zinc intake to maintain metabolic homeostasis.

摘要

经过几十年因其对心血管的不良影响、促炎和致纤维化作用而声名狼藉,血管紧张素转换酶 2(ACE2)于 2000 年被发现,使得肾素-血管紧张素系统(RAS)开始被重新审视。这种单羧肽酶以其代谢血管紧张素(Ang)II 生成 Ang 1-7 的能力而闻名,可对抗 Ang II 介导的 AT1 血管紧张素 II 受体的不良作用。Ang 肽通常被认为是被氨肽酶代谢的,由此衍生出 Ang III(去天冬酰基 Ang II,2-8 七肽)和 Ang IV(去天冬酰基去精氨酸 Ang II,3-8 六肽)的命名。本报告比较了重组人 ACE2(rhACE2)代谢 Ang III、Ang IV 和 Ang V(4-8 五肽)形成相应的去 ω-苯丙氨酸代谢物的能力,与 Ang II 相比。rhACE2 对 Ang III 的亲和力最高(最低 K),其次是 Ang II∼Ang V,其次是 Ang IV。然而,rhACE2 对 Ang IV 的代谢 Kcat 最高,其次是 Ang V、Ang III 和 Ang II。酶学效率(Kcat/Km)对 Ang V 和 Ang III 最高,其次是 Ang IV,对 Ang II 最低。作为一种锌金属肽酶,ACE2 其活性位点需要一个锌分子进行催化。本报告还记录了超过 10 μM 的锌浓度抑制 ACE2 活性。这些观察结果将 ACE2 的功能意义扩展到包括 Ang III、Ang IV 和 Ang V 的代谢失活,再次强调了监测锌摄入量以维持代谢平衡的重要性。